It’s happy hour (for now) for Alnylam
Good morning and happy Wednesday. Today we’re talking about insulin, pharma’s ties with politicians, and…
Category: research
Opinion: Listen: Empathy should be the first response to people with vaccine injury, fears
For scientists and medical professionals well versed in the safety and effectiveness of vaccines, it…
STAT+: Why clinical trials for digital therapeutics are getting more rigorous
Faced with widespread skepticism about the value of digital therapies, Swing Therapeutics in early 2022…
Roche looks to have a competitive GLP-1 drug
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Expansive new study points to distinct brain networks linked to sex and gender
Our brains are shaped by our experiences — whether you’re a bird watcher, book lover,…
Element Biosciences raises another massive round
Want to stay on top of the science and politics driving biotech today? Sign up to get…
CAR-T therapy’s complications, as well as its benefits, become clearer in ‘flurry’ of cancer studies
Researchers were perplexed when the Food and Drug Administration announced it was investigating whether CAR-T…
STAT+: The biggest misconception about CTE, according to a leading brain trauma expert
This week, the late National Hockey League veteran Greg Johnson was diagnosed with chronic traumatic…
Alcohol is driving a half-dozen types of cancer in the U.S., study finds
Alcohol has long been classified as a cancer-causing substance, but a study out Thursday gives…
Can you get satiety with GLP-1s without the nausea?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Researchers identify ‘molecular switch’ in lupus that could stymie harmful immune response
Lupus, in superhero terms, tells a devastating story. A loyal hero turns villain and works…
uniQure shares soar on Huntington’s data
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Expand community-based research to make clinical trials more diverse
Innovations in clinical trial designs and tools have the potential to unlock a new era…
A rare voice box transplant helped a cancer patient speak again, part of a pioneering study
WASHINGTON (AP) — A Massachusetts man has regained his voice after surgeons removed his cancerous…
Lilly’s obesity drug looks more potent than Novo’s in observational study
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: A faster, simpler, cheaper cancer cell therapy is about to be tested in humans
In a long-awaited study, patients in Australia will soon receive an IV infusion designed to…
New study sparks debate about whether H5N1 virus in cows is adapted to better infect humans
A study published Monday provides new evidence that the H5N1 virus currently causing an outbreak…
STAT+: Biden administration appeals jury finding in battle over patents for HIV prevention pills
The Biden administration has appealed a decision in which a federal court jury last year…
Opinion: The ethical implications of Elon Musk’s unorthodox approach to medical science
Medical milestones broadcast via tweet. Scientific progress revealed via live YouTube demo. Teasers for updates…
Constructing an atlas of human biology in space: Q&A with Chris Mason
After several delays, the highly anticipated first commercial spacewalk is set to launch later this…
‘Visionary’ study finds inflammation, evidence of Covid virus years after infection
Remember when we thought Covid was a two-week illness? So does Michael Peluso, assistant professor…
.jpg)
Opinion: Listen: Why is eugenics still alive and well in scientific publishing?
While the bogus science of eugenics — the idea that the human race can be…
Microbiome composition varies based on sampling time, mouse study finds
The microbiome has immense power to shape health outcomes. The bacteria that take up residence…
STAT+: Novel amputation procedure makes walking with a prosthetic leg feel more seamless
A novel surgical technique could dramatically improve walking for people with below-the-knee amputations and help…
STAT+: Medicare’s big experiment to fix kidney failure care hasn’t worked so far, studies say
A few years ago, the Centers for Medicare and Medicaid Services launched a big experiment….
Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Trying to outrun her prion disease, researcher creates powerful epigenetic editor in mice
Sonia Vallabh always thought genome editing wouldn’t be an option. It was such an obvious…
Exclusive: European VC Forbion hires Dyne CEO, expands into US
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Journal retracts study tied to Micronoma’s effort to create blood cancer test
Nature retracted a high-profile paper that served as part of the scientific groundwork for Micronoma,…
Intellia says its CRISPR-based therapy can be redosed
Want to stay on top of the science and politics driving biotech today? Sign up to get…
One firm, two conflicting takes on Alnylam’s HELIOS-B
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: U.K. pharma increasingly violates voluntary industry marketing codes, and probes are taking longer
Pharmaceutical companies in the U.K. have increasingly violated a voluntary industry marketing code but complaints…
Opinion: Turning a ‘no’ vote into progress: How to advance MDMA-assisted psychotherapy for PTSD
Many people have interpreted as a setback the “no” vote by an advisory committee to…
The findings from Alnylam’s highly anticipated readout
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about FDA approval for Sarepta drug, MSF closing access campaign and more
And so, another working week will soon draw to a close. Not a moment too…
Can JAK inhibitors bolster checkpoint inhibitors?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: New immunotherapy combination could ‘change the landscape’ of cancer treatment
When they work, immunotherapy drugs called checkpoint inhibitors can shrink cancers and, in some cases,…
Coalition wages campaign for retractions of Richard Lynn’s racist journal articles
A coalition of researchers, historians, and journalists is urging that major scientific publishers, including Elsevier…
STAT+: Pharmalittle: We’re reading about Lilly lawsuits, Novo Nordisk fires and much more
Rise and shine, everyone, another hot day is on the way. The forecast – at…
Lilly takes more actions against unapproved versions of Mounjaro
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Journals that published Richard Lynn’s racist ‘research’ articles should retract them
In 2012, the Elsevier journal Personality and Individual Differences published a special issue that included…
STAT+: New study bolsters evidence rare genetic mutation can delay early Alzheimer’s
For members of a large extended Colombian family, an early Alzheimer’s diagnosis is practically a…
A new era for NIH
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
A biotech’s binary bet ends badly
Want to stay on top of the science and politics driving biotech today? Sign up to get…
With sweeping NIH reform on the table, GOP previews new era of research scrutiny
WASHINGTON — There seems to be broad agreement that change is coming for the National…
FDA offers new guidelines for Covid-19 vaccine
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Ambitious federal study failed to curb opioid deaths, NIH announces
In 2019, amid an ever-worsening drug crisis, the federal government launched a research study with…
STAT+: Pharmalittle: We’re reading about abortion pill access, employer coverage of GLP-1 drugs and more
And so, another working week will soon draw to a close. Not a moment too…
With Avidity and Pfizer, gene therapy enters a phase
Want to stay on top of the science and politics driving biotech today? Sign up to get…
With placenta-on-a-chip, researchers hope to gauge how drugs and toxins impact pregnancy
Early in her pregnancy in 2015, Nicole Hashemi wanted to know how much caffeine was…